13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)
...... (read more)
Regulus Therapeutics Inc. (RGLS)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 13,685,204 | $2,704 | 0.23% | |
| 2. | Ascend Capital Malcolm Fairbairn | 1,050,935 | $207 | -2% | 0.01% |
| 3. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 4. | Point72 Asset Management Steve Cohen | 0 | $0 | 0% | |
| 5. | Renaissance Technologies Jim Simons | 595,501 | $118 | +397% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.38 | 300,000 | Director | 668,672 | 2018-11-16 | Filing | |
| $1.33 | 200,000 | Director | 368,672 | 2018-11-15 | Filing | |
| $1.41 | 7,100 | Director | 27,596 | 2018-11-16 | Filing | |
| $0.91 | 274,725 | Officer | 274,725 | 2017-07-25 | Filing | |
| $0.91 | 274,725 | Director | 624,625 | 2017-07-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.21 | 111,000 | Large Shareholder | 5,173,172 | 2015-07-17 | Filing | |
| $10.79 | 167,000 | Large Shareholder | 5,284,172 | 2015-07-16 | Filing | |
| $10.76 | 65,133 | Large Shareholder | 5,451,172 | 2015-07-15 | Filing | |
| $10.79 | 13,248 | Large Shareholder | 5,516,305 | 2015-06-30 | Filing | |
| $17.73 | 60,000 | Officer, Director | 3,705 | 2015-04-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 10,989,010 | $26,044 | 1.12% | |
| 2. | 1,697,802 | $4,026 | 0.44% | |
| 3. | 2,614,704 | $517 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 1,834 | $0 | 0% |
News See All
13G Filing: Broadfin Capital and Regulus Therapeutics Inc. (RGLS)
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...... (read more)
Insider Buying at Regulus Therapeutics Inc (RGLS) Sends Stock Soaring
Regulus Therapeutics Inc (NASDAQ:RGLS) shares have jumped $0.30 per share, or 24%, to $1.55 in after hours on Thursday. Traders have bid up shares due to the company disclosing in a regulatory filing...... (read more)
How Regulus Therapeutics Inc (RGLS) Stacks Up Against Its Peers
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...... (read more)
Why Are These Stocks Deep in Red Today?
Among the losers today are Regulus Therapeutics Inc (NASDAQ:RGLS), Vista Gold Corp. (NYSEMKT:VGZ), Babcock & Wilcox Enterprises Inc (NYSE:BW), Barrick Gold Corporation (USA) (NYSE:ABX), and COMSCORE...... (read more)
What’s Going On With These 5 Trending Stocks?
U.S stocks are trading down ever so slightly on this fine Friday afternoon. Even though oil prices are plummeting ahead of the Doha oil producers' meeting this weekend, better-than-feared financial results...... (read more)
Is Regulus Therapeutics Inc (RGLS) Going to Burn These Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly...... (read more)
Trellus Management’s Top Biotech Stock Picks For Q4
Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994. The fund manages client focused equity portfolios and invests in public equity markets around the world...... (read more)
Billionaire Hedge Funds
